Objective: To characterize the relation of the ␤ig-h3 protein to the diagnostic corneal deposits in the hereditary corneal dystrophies recently shown to have mutations in the βig-h3 gene on chromosome 5q31.
I
N 4 clinically different, autosomal dominant corneal dystrophies, specific missense mutations have been reported in the βig-h3 gene (transforming growth factor ␤-induced gene) on chromosome 5q31. [1] [2] [3] These include lattice corneal dystrophy type I (LCD-I), granular dystrophy (GCD), a mixed granular-lattice dystrophy called "Avellino dystrophy" (ACD), and Reis-Bü cklers dystrophy. These dystrophies are defined by their clinical manifestations, combined with the microscopic and histochemical characteristics of their abnormal corneal deposits. Lattice corneal dystrophy type I has stromal deposits of an amyloid, 4 GCD has accumulations of a crystalloid Masson trichrome red material ("hyaline"), 5 and ACD dystrophy contains deposits of both. 6 The name Reis-Bü cklers dystrophy has been used for 2 superficial corneal dystrophies, both severely affecting the Bowman layer. [7] [8] [9] [10] [11] [12] One seems to be a superficial variant of GCD with rod-shaped Masson trichrome red deposits, [13] [14] [15] subclassified by Kü chle et al 12 as corneal dystrophy of Bowman layer I (CDB-I). 12 The more common entity (called ThielBehnke honeycomb dystrophy in Europe 16 ) has deposits of "curly fibers" identifiable only by electron microscopy, 17 and is subclassified as corneal dystrophy of Bowman layer II (CDB-II). 12 The type of Reis-Bü cklers dystrophy reported to have a βig-h3 mutation was not specified, 1 but similarities of the rod-shaped type (CDB-I) to granular dystrophy and mapping of the curly fiber type (CDB-II) to a similar locus on chromosome 5q 18 suggest that they both result from βig-h3 mutations.
The ␤ig-h3 gene product is a prominent protein in the cornea, skin, and matrix of many connective tissues, and is considered to have a binding function in these tissues. [19] [20] [21] [22] [23] [24] How mutations disturb this normal function in the cornea, resulting in the abnormal deposits, is unclear. The strong immunolocalization of ␤ig-h3 we found in the deposits, however, favors the likelihood that these aggregates are composed primarily of ␤ig-h3 protein.
RESULTS

NORMAL CORNEAS
The normal corneal epithelium did not stain with ␤ig-h3 antibody. The Bowman layer had the most concentrated diffuse stain by light microscopy (Figure 1, A) . Stromal staining was moderate, outlining the pale horizontal and oblique collagen lamellae by gold labeling along their interfaces. Labeling was less intense but diffuse on the Descemet membrane. No staining of cells or changes with aging were seen.
Ultrastructurally, occasional gold-labeled antibody was seen in the epithelial basement membrane, and on some anchoring fibrils as they passed into the Bowman layer (Figure 2, A) . There was diffuse scattered gold label as single particles and clumps among the collagen fibers of the Bowman layer. A few unlabeled 3-to 5-nm thin wavy fibrils suggestive of collagen VI coursed among the collagen fibers. In the stroma, ␤ig-h3 label was primarily along the junctions of large lamellar layers and scanty within lamellae (Figure 2, B) , as clearly visible at interfaces between obliquely oriented lamellar bundles (Figure 2, C) . Label was also denser on the 20-to 25-nm stromal fibers as they fanned out to attach on the Descemet membrane (Figure 2, D) . The Descemet membrane had moderate clumped label in its outer fetal banded and nonbanded portions, decreasing to none close to the endothelial level (Figure 2 , E).
LATTICE CORNEAL DYSTROPHY TYPE I
In LCD-I, typical fusiform deposits of different sizes occurred in all levels of the stroma, but mostly in the inner two thirds (Figure 1 , B). They were Congophilic and showed apple-green birefringence on polarization, which is diagnostic of amyloid (Figure 1, C) . Ultrastructurally, the abnormal deposits were strongly labeled for ␤ig-h3 protein (Figure 3, A) , in much higher concentration and quantity than in any normal corneal region, as was also true for the ␤ig-h3-positive deposits in the other dystrophies. The characteristic tapering ends of the aggre-
MATERIALS AND METHODS
MATERIALS
Corneal buttons were obtained after corneal transplantation from 2 corneas with LCD-I, 4 corneas with GCD, 2 corneas with ACD, 1 cornea with CDB-I, and 2 corneas with CDB-II. Corneas from normal donors of 20, 39, 45, 67, 69, and 73 years of age were obtained less than 16 hours post mortem from the Central New York Eye Bank, Syracuse, and processed similarly to the dystrophic corneas.
The ␤ig-h3 antibody for immunostaining was made in rabbits to recombinant protein including the fulllength complementary DNA sequence (210-683) of human ␤ig-h3. 19, 22 This antibody reacts on Western blots with purified ␤ig-h3 protein isolated from corneal extracts and identified in gel bands by amino-terminal sequence analysis. 20 Secondary antibodies were biotinylated goat antirabbit used with a Vectastain Elite ABC kit (Vector Laboratories, Burlingame, Calif), or gold-labeled goat antirabbit antibody (E. Y. Laboratories Inc, San Mateo, Calif). Lowicryl K4M resin (Ted Pella Inc, Redding, Calif) and Embed-812 epoxy resin (Electron Microscopy Sciences, Fort Washington, Pa) were used for electron microscopic embedding.
METHODS
Immunohistochemistry and Histological Staining
Dystrophic and normal corneas were fixed in either freshly prepared 4% paraformaldehyde in 0.1-mol/L cacodylate buffer, pH 7.4, overnight at 4°C or in 10% neutral buffered formaldehyde at room temperature. Half of each cornea was dehydrated in ethanol and embedded in paraffin for light microscopy and the other half used for electron microscopy. For light microscopic immunostaining, 3-µm sections were deparaffinized, rehydrated in 0.01-mol/L phosphate-buffered saline (PBS), incubated in 3% hydrogen peroxide for 10 minutes at room temperature, and blocked for 1 hour with 3% nonfat dry milk in PBS and 2% bovine albumin. Slides were incubated for 1 hour at room temperature in ␤ig-h3 antibody at 1:2000 dilution in PBS and 2% bovine albumin. Following rinses, biotinylated secondary antibody (1:200) was applied for 20 minutes, followed by ABC complex with diaminobenzidine as chromagen, and counterstaining with hematoxylin. Substitution of normal rabbit serum and omission of primary antibody were used as controls.
Paraffin sections of dystrophic and normal corneas were all stained routinely with Masson trichrome, Congo red, and periodic acid-Schiff stains for histopathological diagnoses.
Immunoelectron Microscopy
The dystrophic and normal corneal buttons for electron microscopy were sampled in both peripheral and central regions, including superficial, middle, and deep stromal Descemet membrane areas. The specimens were primarily fixed in 4% paraformaldehyde in 0.1-mol/L cacodylate buffer. They were dehydrated in methanol to 90% and embedded in resin at temperatures decreasing to −25°C, and polymerized under UV light as directed. Ultrathin sections were placed on uncoated nickel grids, and blocked in 3% nonfat dry milk with PBS and 2% bovine albumin for 30 minutes. Grids were incubated in ␤ig-h3 antibody at 1:2000 in PBS with 2% bovine albumin in PBS overnight at 4°C. After additional blocking for 30 minutes, 10-nm goldlabeled secondary antibody (1:20) was applied for 30 minutes at room temperature. Sections were postfixed in 2% osmium tetroxide for 10 minutes, counterstained with uranyl acetate-lead citrate, and examined with a transmission electron microscope. Controls were the same as used for immunohistochemistry. For nonimmunostaining electron microscopy, specimens were fixed in 2.5% glutaraldehyde or transferred to it secondarily, and processed routinely in epoxy resin.
gates were seen to lie between collagen lamellae ( Figure  3, A) , where a thin layer of ␤ig-h3 epitopes is found normally. At high magnification the 8-to 10-nm amyloid fibrils showed a typical matted pattern (Figure 3 , B). Labeling for ␤ig-h3 protein in the rest of the cornea appeared mildly reduced.
GRANULAR CORNEAL DYSTROPHY
By light microscopic histochemical analysis, the angular dense deposits of GCD in the superficial and midstroma showed a typical bright red positivity with the Masson trichrome stain (Figure 1, D) . These crystalloid deposits were very electron dense ultrastructurally, with only a few small fenestrations, and labeled intensely for the ␤ig-h3 protein (Figure 4, A) . Under high magnification they showed a structure of fine fibrils, 2 to 3 nm in diameter, and were more electron dense peripherally.
The collagen fibers of the Bowman layer were unlabeled (Figure 4, B) . Labeling for ␤ig-h3 protein in the surrounding stroma was mildly reduced, but appeared normal in the Descemet membrane and the deep attaching collagen fibers.
SUPERFICIAL GRANULAR DYSTROPHY WITH ROD-SHAPED DEPOSITS (CDB-I)
A superficial corneal dystrophy diagnosed clinically as Reis-Bü cklers dystrophy showed by light microscopy alternating horizontal layers of collagen and confluent deposits of small Masson trichrome red rods, replacing the Bowman layer (Figure 1, E) . By electron microscopy the deposits consisted of a plethora of 0.58-to 1.87-µm rodlike bodies, often 0.3 µm in thickness and tending to stack together in layers, producing some thicker and longer forms ( intensely immunoreactive for ␤ig-h3 protein ( Figure 5 , B). At high magnification a faint stippled-fibrillar structure was seen ( Figure 5 , B, inset), much finer than in the usual GCD (Figure 4, B) . In the central cornea, small deposits of a similar nature were present in the deeper stroma.
MIXED GRANULAR-LATTICE DYSTROPHY
The corneas with ACD had areas of confluent and isolated Masson trichrome red deposits superficially, tending to elevate the epithelium, associated with irregular loss of the Bowman layer (Figure 1, F) . The stromal amyloid deposits (Figure 1 , G) resembled those in LCD-I but small patches were also seen in the region of the Bowman layer. Ultrastructurally the superficial aggregates were very electron dense but not as heavily labeled for ␤ig-h3 protein as in the usual GCD. They contained numerous lucent spaces (Figure 6 , A) surrounded by welllabeled amorphous material. At high magnification the dense deposits were featureless, merging with the adjacent fine fibrillogranular material (Figure 6 , B). The deeper stromal amyloid deposits were strongly labeled, infiltrating between the collagen bundles similar to those in LCD-I, although their 6-to 8-nm fibrils were thinner (Figure 6, C) . The intervening stroma showed some reduction in ␤ig-h3 binding, but the Descemet membrane had normal staining. Linear fibrils in the superficial region were less densely labeled than the stromal amyloid, and were mixed with fine ␤ig-h3-labeled material (Figure 6 , D). Under degenerating epithelial cells, there were labeled aggregates of GCD-like but looser fibrillar material ( Figure 6 , D, inset).
THIEL-BEHNKE DYSTROPHY
In 2 patients with CDB-II dystrophy, saw-toothing of the epithelium over undulating subepithelial mounds and loss of the Bowman layer were noted by light microscopy (Figure 1, H) . The ␤ig-h3 antibody binding in the subepithelial region showed a diffuse pattern with intensely positive short strands and small clumps (Figure 1, I ). Ultrastructurally, the characteristic 12-to 16-nm curly fibers were very electron dense and most distinct after routine epoxy resin embedding, where the collagen in the Bowman layer and superficial stroma stained only faintly with the uranyl acetate-lead citrate counterstain (Figure 7, A) . The curly fibers were often in packets of 2 to 3 curved short fibers stacked together, sometimes attaching to fragments of interrupted epithelial basement membrane. In immunostained Lowicryl sections, the curly fibers were strongly reactive for ␤ig-h3 protein (Figure 7, B) . There was no gold label on the intervening collagen fibers, which were now more visible with the counterstain. Aggregates of curly fibers formed broad ␤ig-h3-labeled networks extending into the superficial stroma. These tracked along the interlamellar junctions, clearly visible in oblique sections (Figure 7, C) and reminiscent of the normal concentration of ␤ig-h3 epitopes at lamellar interfaces. Degenerate keratocytes and cell debris were more common than in most of the other dystrophies. The Descemet membrane had normal staining for ␤ig-h3 protein.
COMMENT
The diffuse immunopositivity for ␤ig-h3 in lesions of LCD-I, GCD, ACD, and both rod-shaped and curly fiber types of Reis-Bü cklers dystrophy is consistent with reports of their association with missense mutations in the βig-h3 gene. [1] [2] [3] The marked affinity of the ␤ig-h3 antibody for the diagnostic deposits at high dilution and in greater concentration than in any area of the normal cornea indicates that this protein is a major component of the deposits, if not the main one. Supporting this hypothesis is evidence that ␤ig-h3 protein is extractable in excess amounts from corneas with granular corneal dystrophy. 20 Whether the deposits in these autosomal dominant dystrophies are composed solely of the mutant form of ␤ig-h3 protein or contain a mixture of mutant and normal protein is currently unknown.
In 2 of our corneas diagnosed clinically as having Reis-Bü cklers dystrophy, the presence of curly fibers ultrastructurally identified them as the Thiel-Behnke or CDB-II type. 12, 16, 17 A third cornea, with the same clinical diagnosis, had the confluent form of superficial GCD, with a plethora of Masson trichrome red rodlike deposits, [7] [8] [9] [10] [11] [12] [13] [14] [15] called the CDB-I type of Reis-Bü cklers by Kü chle et al. 12 The specific although quite different deposits in CDB-I and CDB-II were strongly ␤ig-h3-positive, supporting an origin for both Thiel-Behnke curly fiber and superficial granular rod-shaped dystrophies from mutations in the βig-h3 gene. It has not been shown whether both variants result from the same missense mutation in codon 555 (R555Q) of the βig-h3 gene found by Munier et al 1 in an unspecified case of Reis-Bü cklers dystrophy. Alternatively, the CDB-I type might share the GCD mutation (R555W) in the same codon or involve a mutation elsewhere in the gene. The ultrastructural and molecular genetic spectrum of Reis-Bü cklers-like clinical entities may not yet be fully known, as another dystrophy reported to be a ThielBehnke type has recently been mapped to the long arm of chromosome 10 (10q23-q24). 25 The ␤ig-h3 protein appears to be an important structural component in collagenous connective tissues. It is widely distributed and can be produced by both mesenchymal and epithelial cells, as shown in the earliest reports, 19, 22, 23 so the term "kerato-epithelin," used for ␤ig- h3 protein in the corneal dystrophies, 1-3 may be too restrictive for general usage. It seems to have an adhesive function and a role in regulation of growth and differentiation. 19, 24 In the normal adult cornea, the distribution of ␤ig-h3 protein was similar to that in previous studies, 26 which suggested an anchoring function between the corneal stroma and the adjacent Descemet membrane and subepithelial tissues. In the present study, postembedding staining showed the major stromal binding of ␤ig-h3 antibody was at interfaces between collagen lamellae and at junctions of collagen bundles attaching to disparate types of collagen such as in the Descemet membrane, and diffusely in the Bowman layer. A similar distribution in the bovine cornea and other collagenous tissues has been suggested to represent a "bridging" function for ␤ig-h3 protein. 24 There is increasing evidence that ␤ig-h3 protein colocalizes with type VI collagen in many tissues. 24, 26, 27 The fine, wavy 3-to 4-nm fibrils we noted in the normal Bowman layer and at interlamellar junctions appeared to be collagen VI morphologically, but identification must be confirmed by specific immunostaining.
The similarity in distribution of dystrophic aggregates and the normal pattern of ␤ig-h3 protein is noteworthy, with heaviest concentration in the Bowman region in the superficial dystrophies, and infiltration between lamellar tissue planes in dystrophies extending into the stroma. The continued expression of ␤ig-h3 in fetal and adult corneal epithelium 27, 28 might lead to earlier and greater accumulation of mutant protein in the superficial dystrophies. Slower and later deposition in the stroma could be due to the low level of βig-h3 gene expression in stromal cells beyond fetal life, except in healing or disease processes. 26, 27 The frequency of degenerate epithelial and stromal cells in the dystrophies suggests that the protein over time is damaging to cells, whose death could add proteolytic factors, further potentiating abnormal ␤ig-h3 protein polymerization.
How the βig-h3 gene mutations result in the structural changes seen in the dystrophic aggregates is a more complex problem. Munier et al 1 suggest that the mutation in codon 555 in both GCD and Reis-Bü cklers dystrophy could interrupt a predicted coiled-coil domain, allowing precipitation of proteins and formation of dimers and rod forms. 29 The substitutions in codon 124 resulting in lattice lesions in LCD-I and ACD were suggested to be amyloidogenic, 1 possibly from abolishing a phosphorylation site. Further explanation is required, however, for the associated granular changes in ACD.
The variety of structural forms resulting from accumulation of ␤ig-h3 proteins in the dystrophic aggregates is considerable, raising the question of whether other corneal components contribute to the aggregates. Substances reported to date include lectin-positive carbohydrate in LCD-I, GCD, and ACD, 6, 30 amyloid P protein in LCD-I, 30 and phospholipids in GCD. 31 Mutant ␤ig-h3 protein may bind these lipid and carbohydrate moieties aberrantly so they become incorporated in the deposits. Thus the aggregate structure could be related to both the specific mutation and availability of other components in the matrix. The proportion of mutated protein and genetic differences in other matrix components may also affect the resultant forms, as suggested by the wide variation in clinical phenotype in some families with ACD. 32 Further study of ␤ig-h3 mutations is expected to give valuable insights into the role of ␤ig-h3 protein in normal corneal structure and function, and potentially lead to innovations in treatment of these dystrophies. October 2, 1998 . 
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